Treatment for Recurrent Herpes Whitlow

Antiviral Treatment Options

The American College of Physicians recommends valacyclovir 500 mg orally twice daily for 5 days as the first-line treatment for recurrent herpes whitlow 1, 2
Alternative treatment options include acyclovir 400 mg orally three times daily for 5 days, as recommended by the Centers for Disease Control and Prevention 1, 2
The Infectious Diseases Society of America suggests acyclovir 800 mg orally twice daily for 5 days as an alternative treatment option 1, 3
Famciclovir 125 mg orally twice daily for 5 days is also recommended by the American Academy of Dermatology 1, 3

The Centers for Disease Control and Prevention recommends that treatment is most effective when started during the prodromal phase or within 1 day after onset of lesions 1, 2
Early treatment can significantly reduce the duration of symptoms and viral shedding, according to the MMWR Recommendations and Reports 4, 5

Topical acyclovir is substantially less effective than oral therapy and is not recommended by the MMWR Recommendations and Reports 4, 3
For immunocompromised patients with severe disease, intravenous acyclovir may be necessary, as suggested by the Infectious Diseases Society of America 4

The American College of Physicians recommends that for patients with frequent recurrences (≥6 episodes per year), daily suppressive therapy should be considered 1, 2
Suppressive therapy options include valacyclovir 1 g orally once daily, as recommended by the American Academy of Dermatology 1
Acyclovir 400 mg orally twice daily is also a recommended suppressive therapy option by the Centers for Disease Control and Prevention 1, 2
Suppressive therapy can reduce recurrence frequency by ≥75%, according to the American College of Physicians 1

The American Academy of Dermatology advises patients that herpes whitlow is a recurrent, incurable viral infection 1, 3
Antiviral medications control symptoms but do not eradicate the virus or prevent all recurrences, as recommended by the Infectious Diseases Society of America 1, 3

The Centers for Disease Control and Prevention states that antiviral resistance is rare in immunocompetent patients but more common in immunocompromised individuals 2
If treatment failure occurs, viral cultures with susceptibility testing should be considered, as recommended by the MMWR Recommendations and Reports 4
For acyclovir-resistant herpes, foscarnet 40 mg/kg IV three times daily or 60 mg/kg twice daily is the treatment of choice, according to the Infectious Diseases Society of America 4